Annals of Oncology 8:S53-S56, 1997
© 1997 European Society for Medical Oncology
Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease
1 Division of Medical Oncology A, Istituto Naztonale Tumori Milan, Italy
2 Division of Nuclear Medicine, Istituto Naztonale Tumori Milan, Italy
3 Division of Dragnostic Radiology, Istituto Naztonale Tumori Milan, Italy
1Correspondence to: Dr. Liliana Devizzi Division of Medical Oncology A Istituto Nazionale Tumori Via Venezian, 1 20133 Milan, Italy
Background In patients with Hodgkin's disease, the use of gallium-67 scintigraphy (Ga-67) compared to conventional staging and restaging techniques is still controversial. In particular, in a combined modality treatment with chemotherapy and radiotherapy given in sequence, its role in detecting active disease after chemotherapy may be useful in planning the subsequent radiotherapeutic strategy.
Patients and methods From March 1990 to September 1994, 125 patients with previously untreated histologically proven Hodgkin's disease were enrolled in two different prospective trials according to clinical stage. Staging procedures included Ga-67, chest-abdominal computed tomography (CT), and/or magnetic resonance (MR). All three tests were performed in 53 patients at staging and in 47 at restaging. Results of Ga-67 at staging were compared to conventional procedures or pathological findings. Results of Ga-67, CT scan, and MR at restaging were compared to disease outcome during the follow-up. Finally a cost/benefit ratio for each test was determined.
Results At staging, Ga-67 showed lower sensitivity than CT and MR (90 vs. 96 and l00%, respectively) because of the number of false-negative images. Nevertheless, by using both CT and Ga-67 scan, the sensitivity is equal to that observed with MR (100%). At restaging, Ga-67 is superior to CT scan and equivalent to MR in detecting true negative patients (specificity: 98% vs. 45% vs. 92%).
Conclusions As a single technique, Ga-67 scan cannot substitute for CT scan or MR in staging patients with Hodgkin's disease. Nevertheless, Ga-67 scan has an important role in defining complete remission after treatment and therefore in planning subsequent treatment. Considering the lower costs of CT scan plus Ga-67 ($320) versus MR alone ($810), the two tests may be considered procedures of choice in staging as well as in restaging patients with Hodgkin's disease.
computed tomography, gallium scan, magnetic resonance, mediastinal Hodgkin's disease
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Rahmouni, M. Divine, E. Lepage, N. Jazaerli, K. Belhadj, P. Gaulard, M. Golli, F. Reyes, and N. Vasile Mediastinal Lymphoma: Quantitative Changes in Gadolinium Enhancement at MR Imaging after Treatment Radiology, June 1, 2001; 219(3): 621 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Jerusalem, Y. Beguin, M.F. Fassotte, F. Najjar, P. Paulus, P. Rigo, and G. Fillet Whole-Body Positron Emission Tomography Using 18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin's Disease and Non-Hodgkin's Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging Blood, July 15, 1999; 94(2): 429 - 433. [Abstract] [Full Text] [PDF]
|
|